JUSTEN BICKETT: Open Payments
NPI 1033657895 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 64 payments from 19 companies in 2025. Trend: 2023 $922 · 2024 $664 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $172 |
| Lilly USA, LLC | 10 | $148 |
| ABBVIE INC. | 8 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| PFIZER INC. | 4 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
Products named: Ozempic, MOUNJARO, CAPLYTA, REXULTI, JARDIANCE, GEMTESA, VRAYLAR, UBRELVY.
Industry payments across KY — which companies pay providers there.
